Read further: Therapeutic Potential of FPR Agonist Cmpd17b in Hypertension-Induced End-Organ Damage
Most Recent Articles
Therapeutic Potential of FPR Agonist Cmpd17b in Hypertension-Induced End-Organ Damage
Formylpeptide receptors (FPRs) are crucial in regulating inflammation, a critical factor in hypertension-induced end-organ damage. Previous studies have highlighted the cardioprotective effects of the biased FPR small-molecule...
Influence of Alcohol and Hypoxia on Cardiovascular Parameters during Flight
Long-haul flights often involve passengers consuming alcohol, and the combination of inflight sleep and hypobaric hypoxia can significantly impact physiological parameters such as blood oxygen saturation (SpO2) and heart rate...
Xylitol and Cardiovascular Risk: Metabolomic Insights and Platelet Reactivity
Understanding the residual risks contributing to cardiovascular diseases remains a critical area of research. Low-calorie sweeteners, commonly used as sugar substitutes in processed foods, are perceived to offer health advantages...
Impact of PFAS Exposure on Cardiovascular Health in Postmenopausal Women
Cardiovascular diseases (CVDs) are a leading cause of mortality worldwide, influenced by various factors, including environmental exposures like per- and polyfluoroalkyl substances (PFASs). PFASs, persistent environmental...